Buniva G, Sassella D, Beretta E
Int J Clin Pharmacol Biopharm. 1977 Oct;15(10):460-7.
The plasma levels of diftalone, its metabolite 7-hydroxydiftalone, unconjugated and total paracetamol have been assessed in 6 healthy volunteers after oral administration of diftalone 0.75 g and of paracetamol 1.0 g, given alone and in combination in a cross-over fashion. In the same subject the urinary elimination of 7-hydroxydiftalone, and of unconjugated and total paracetamol has also been estimated. The results provide some indication of a slight increase in the plasma levels of unconjugated and total paracetamol, when the drug is administered in combination with diftalone. The increase, however, does not reach the significance level. As to diftalone and its metabolite, the differences between the plasma levels obtained after administration of the compound alone and those obtained when it was given in combination were negligible. Furthermore, the urinary recoveries of 7-hydroxydiftalone and of unconjugated and total paracetamol were very similar after administration of each compound alone and of their combination. It is concluded that the administration of single doses of diftalone and paracetamol in combination does not produce any pharmacokinetic interaction likely to be of clinical relevance.
在6名健康志愿者中,以交叉方式分别单独及联合口服0.75 g二氟拉松和1.0 g对乙酰氨基酚后,评估了二氟拉松及其代谢物7-羟基二氟拉松、游离及总对乙酰氨基酚的血浆水平。在同一受试者中,还估计了7-羟基二氟拉松、游离及总对乙酰氨基酚的尿排泄情况。结果表明,当二氟拉松与对乙酰氨基酚联合给药时,游离及总对乙酰氨基酚的血浆水平略有升高。然而,这种升高未达到显著水平。至于二氟拉松及其代谢物,单独给药后获得的血浆水平与联合给药时获得的血浆水平之间的差异可忽略不计。此外,单独给药每种化合物及其组合后,7-羟基二氟拉松、游离及总对乙酰氨基酚的尿回收率非常相似。结论是,单剂量联合使用二氟拉松和对乙酰氨基酚不会产生任何可能具有临床相关性的药代动力学相互作用。